BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Takeda Pharmaceuticals

1 post
Takeda Inks Licensing Deal with Degron Therapeutics for Molecular Glue Degraders

Biotech NewsTakeda Inks Licensing Deal with Degron Therapeutics for Molecular Glue Degraders

  • BioTech Health X
  • May 23, 2024
Takeda Pharmaceuticals has announced an exclusive licensing agreement with Degron Therapeutics, a Chinese biotech company, to develop novel…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Arcutis (ARQT) Achieves $44.8M in Q3 2024 Revenue, Growing 452% Year-Over-Year
  • Amylyx (AMLX) Reports $234.4M in Cash, Secures Financial Stability Through 2026
  • MiMedx (MDXG) Reports $84M in Q3 2024 Sales, Showcasing Financial Growth
  • Cassava Sciences (SAVA) Secures $149M to Support Simufilam Trials Into 2026
  • Puma Biotechnology (PBYI) Reports $140.8M NERLYNX® Revenue in 2024 Amid Operational Excellence
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • December 23, 2024
    Arcutis (ARQT) Achieves $44.8M in Q3 2024 Revenue, Growing 452% Year-Over-Year
    • December 23, 2024
    Amylyx (AMLX) Reports $234.4M in Cash, Secures Financial Stability Through 2026
    Biogen Expands Immunology Portfolio with Strategic Acquisition
    • December 22, 2024
    MiMedx (MDXG) Reports $84M in Q3 2024 Sales, Showcasing Financial Growth
    • December 22, 2024
    Cassava Sciences (SAVA) Secures $149M to Support Simufilam Trials Into 2026
    • December 22, 2024
    Puma Biotechnology (PBYI) Reports $140.8M NERLYNX® Revenue in 2024 Amid Operational Excellence
Recent Posts
  • Lakeside Holding (LSH) Deepens Roots in Pharmaceutical Logistics with $1.5M Sinopharm Agreement
    • December 17, 2024
  • NeuBase (NBSE)’s PATrOL™ Platform: The Future of RNA-Targeted Therapies
    • December 15, 2024
  • Analysts Maintain Optimism as Lexicon Pharmaceuticals (LXRX) Focuses on Long-Term Growth
    • December 15, 2024
Categories
  • BioTech CEO Interviews (5)
  • Biotech Info (1)
  • Biotech News (101)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top